Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Co-Diagnostics, Inc. (CODX)

0.3533 -0.0134 (-3.65%)
At close: 4:00:01 PM EST
0.3700 +0.0167 (+4.73%)
After hours: 4:31:51 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
721.3860
622.4890
3,915.1600
6,812.0380
34,218.2090
Cost of Revenue
407.7520
222.3770
999.1240
4,184.9490
5,481.0930
Gross Profit
313.6340
400.1120
2,916.0360
2,627.0890
28,737.1160
Operating Expense
30,396.4620
31,683.4640
42,997.3460
45,333.3230
40,328.4070
Operating Income
-30,082.8280
-31,283.3520
-40,081.3100
-42,706.2340
-11,591.2910
Net Non Operating Interest Income Expense
291.6420
292.9320
1,091.8250
1,161.9130
704.0450
Other Income Expense
-18,885.8070
-17,521.4940
1,407.8450
3,433.7650
-7,959.9880
Pretax Income
-48,676.9930
-48,511.9140
-37,581.6400
-38,110.5560
-18,847.2340
Tax Provision
-1,620.6210
-1,615.9780
57.3680
-2,777.6910
-4,608.9850
Net Income Common Stockholders
-47,056.3720
-46,895.9360
-37,639.0080
-35,332.8650
-14,238.2490
Diluted NI Available to Com Stockholders
-47,056.3720
-46,895.9360
-37,639.0080
-35,332.8650
-14,238.2490
Basic EPS
-25.89
-35.25
-37.22
-36.00
-13.50
Diluted EPS
-25.89
-35.25
-37.22
-36.00
-13.50
Basic Average Shares
2,430.8800
1,330.1990
1,011.1780
978.2190
1,049.3000
Diluted Average Shares
2,430.8800
1,330.1990
1,011.1780
978.2190
1,049.3000
Total Operating Income as Reported
-48,964.8280
-50,165.3520
-40,081.3100
-42,706.2340
-26,979.8370
Total Expenses
30,804.2140
31,905.8410
43,996.4700
49,518.2720
45,809.5000
Net Income from Continuing & Discontinued Operation
-47,056.3720
-46,895.9360
-37,639.0080
-35,332.8650
-14,238.2490
Normalized Income
-28,892.7355
-29,997.4244
-38,824.4004
-38,422.6135
-8,479.8497
Interest Income
291.6420
292.9320
1,091.8250
1,161.9130
704.0450
Net Interest Income
291.6420
292.9320
1,091.8250
1,161.9130
704.0450
EBIT
-30,082.8280
-31,283.3520
-40,081.3100
-42,706.2340
-11,591.2910
EBITDA
-29,090.5940
-30,176.5440
-38,704.0440
-41,475.7600
-10,308.5730
Reconciled Cost of Revenue
407.7520
222.3770
999.1240
4,184.9490
5,481.0930
Reconciled Depreciation
992.2340
1,106.8080
1,377.2660
1,230.4740
1,282.7180
Net Income from Continuing Operation Net Minority Interest
-47,056.3720
-46,895.9360
-37,639.0080
-35,332.8650
-14,238.2490
Total Unusual Items Excluding Goodwill
-18,789.1920
-17,475.1930
1,593.9120
3,333.0620
-7,627.0190
Total Unusual Items
-18,789.1920
-17,475.1930
1,593.9120
3,333.0620
-7,627.0190
Normalized EBITDA
-10,301.4020
-12,701.3510
-40,297.9560
-44,808.8220
-2,681.5540
Tax Rate for Calcs
0
0
0.0003
0.0001
0.0002
Tax Effect of Unusual Items
-625.5555
-576.6814
408.5196
243.3135
-1,868.6197
12/31/2022 - 7/12/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: